Multiple Myeloma: A Textbook for Nurses | Third editionBy: Joseph D. Tariman, School of Nursing; Beth Faiman, Cleveland Clinic Myeloma Program
This third edition presents cutting-edge information on novel treatments and nursing care of patients with multiple myeloma receiving these novel therapies. The contributors are expert clinicians who developed new chapters that incorporate developments in genomics and biomarkers' therapeutic applications. "Multiple Myeloma" also covers promising clinical drug trials and major breakthroughs in clinical practice in the past decade.
What’s the most surprising thing you learned while writing this book?
I am amazed at the rapid expansion of therapeutic options for patients with multiple myeloma. Despite its rare cancer status, the biotech industry has addressed the most crucial needs for curbing the high mortality and morbidity rate associated with this deadly disease.
Persuade someone to read your book in less than 50 words:
This book is the ultimate resource for nurses and nurse practitioners caring for patients with myeloma. There is no other print material with such depth and breadth in examining the therapeutic breakthroughs and the management of patients receiving these breakthrough therapies.
About the author:
An associate professor at DePaul, Joseph Tariman began his research career in 2002 as a member of the myeloma program research team at Northwestern University. His first research study examined the QOL in older myeloma patients who underwent autologous HSCT. Subsequently, he has served as co-investigator in many clinical drug trials in myeloma, which gave him the opportunity and credibility to serve as a key opinion leader, editor of the only myeloma book for nurses, leading other clinicians in manuscript preparation, submission, and publication of the several peer-reviewed journal articles on clinical topics such as novel myeloma therapies, management of novel treatment-related side effects in myeloma, cancer survivorship, health maintenance, stem cell transplantation and outcomes measurement.
Publisher and publication date:
Oncology Nursing Society; 2021
Signed by the Author allows DePaul faculty and staff to introduce their recently published or upcoming book or chapter to the university community. To submit your book or chapter for consideration, contact Newsline.